JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Husain, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Husain, S. S.
Journal of Nuclear Medicine Technology Volume 35, Number 1, 2007 3-9
© 2007 by Society of Nuclear Medicine

Myocardial Perfusion Imaging Protocols: Is There an Ideal Protocol?*

Syed Sajid Husain

Department of Nuclear Medicine/PET, VA Western New York Healthcare System, Buffalo, New York

Correspondence: For correspondence or reprints contact: Syed Sajid Husain, 3495 Bailey Ave., Buffalo, NY 14215. E-mail: syed.husain{at}med.va.gov

ABSTRACT

Is there an ideal myocardial perfusion imaging protocol? In order to answer this question and choose a protocol for clinical use, one must understand the characteristics of the available radiopharmaceuticals, the protocol variables, and the advantages and disadvantages of each. After reading this article, the technologist should be able to list the ideal characteristics of a myocardial perfusion imaging agent, describe and compare the characteristics of myocardial perfusion imaging agents, discuss the relationship between coronary blood flow and myocardial uptake of various tracers, describe imaging protocols, and discuss the advantages and disadvantages of each protocol.

Key Words: myocardial perfusion imaging; tracer kinetics; coronary blood flow; myocardial uptake; 201Tl; 99mTc




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
S. Goel, S. Bommireddipalli, and E. G. DePuey
Effect of Proton Pump Inhibitors and H2 Antagonists on the Stomach Wall in 99mTc-Sestamibi Cardiac Imaging
J. Nucl. Med. Technol., December 1, 2009; 37(4): 240 - 243.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. L. Baggish and C. A. Boucher
Radiopharmaceutical Agents for Myocardial Perfusion Imaging
Circulation, October 14, 2008; 118(16): 1668 - 1674.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2007 by the Society of Nuclear Medicine Technologist Section.